![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07J 43/00 | (2006.01) |
A61K 31/57 | (2006.01) | ||
A61K 31/573 | (2006.01) | ||
A61K 31/58 | (2006.01) | ||
A61P 25/00 | (2006.01) | ||
C07J 3/00 | (2006.01) | ||
C07J 7/00 | (2006.01) | ||
C07J 15/00 | (2006.01) | ||
C07J 1/00 | (2006.01) | ||
C07J 5/00 | (2006.01) | ||
C07J 13/00 | (2006.01) | ||
C07J 21/00 | (2006.01) | ||
C07J 31/00 | (2006.01) |
(11) | Number of the document | 3498725 |
(13) | Kind of document | T |
(96) | European patent application number | 18203320.9 |
Date of filing the European patent application | 2014-04-17 | |
(97) | Date of publication of the European application | 2019-06-19 |
(45) | Date of publication and mention of the grant of the patent | 2021-06-09 |
(46) | Date of publication of the claims translation | 2021-09-27 |
(30) | Number | Date | Country code |
PCT/CN2013/074323 | 2013-04-17 | WO |
(72) |
BOTELLA, Gabriel Martinez , US
HARRISON, Boyd, L. , US
ROBICHAUD, Albert, Jean , US
SALITURO, Francesco G. , US
BERESIS, Richard Thomas , CN
|
(73) |
Sage Therapeutics, Inc. ,
215 First Street, Cambridge, MA 02142,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Steroidas su 19-nor C3,3-dipakeistuoju C21-N-pirazolilu, skirtas naudoti terapijoje |
19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID FOR USE IN THERAPY |
Payment date | Validity (years) | Amount | |
2025-03-18 | 12 | 289.00 EUR |
2026-04-17 |